sar425899 glucagon glp-1 dual agonist sanofi Receptor occupancy of glucagon-like peptide 1/glucagon receptor in individuals with type 2 diabetes Transforming obesity: The advancement of

Strategies to facilitate medication adherence, persistence and treatment intensification in people with T2D should be made a priority in order to achieve and maintain glycaemic targets and improve outcomes in this population

Coronary artery disease (CAD)cardiovascular condition occuring due to atherosclerotic plaque accumulation in the epicardial arteriesis responsible for disa...

Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database

Although research is currently limited, this is what we know so far.

There is no confirmed elevated risk of suicidality, but surveillance remains warranted